{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:41:28Z","timestamp":1791189688402,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ejps.2015.03.020","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T03:08:27Z","timestamp":1428635307000},"page":"45-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"special_numbering":"C","title":["A review of morphine and morphine-6-glucuronide\u2019s pharmacokinetic\u2013pharmacodynamic relationships in experimental and clinical pain"],"prefix":"10.1016","volume":"74","author":[{"given":"Eva","family":"Sverrisd\u00f3ttir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine Meldgaard","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Estrup","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8rn Mohr","family":"Drewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lona Louring","family":"Christrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Kreilgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.03.020_b0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3565(25)12068-5","article-title":"Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling","volume":"275","author":"Aasmundstad","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1742-7843.2010.00649.x","article-title":"Pharmacokinetic\/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models","volume":"108","author":"Andresen","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2015.03.020_b0015","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00000542-200005000-00038","article-title":"Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action","volume":"92","author":"Angst","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.psy.44.2.167","article-title":"Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I","volume":"44","author":"Armstrong","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ejps.2015.03.020_b0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(25)20113-6","article-title":"Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat","volume":"278","author":"Bickel","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejpain.2010.09.007","article-title":"A randomised controlled trial on the efficacy and side-effect profile (nausea\/vomiting\/sedation) of morphine-6-glucuronide versus morphine for post-operative pain relief after major abdominal surgery","volume":"15","author":"Binning","year":"2011","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejps.2015.03.020_b0035","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1046\/j.1471-4159.2003.01990.x","article-title":"Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier","volume":"86","author":"Bourasset","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2015.03.020_b0040","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1023\/A:1026414713509","article-title":"Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats\u2013a microdialysis study","volume":"17","author":"Bouw","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2015.03.020_b0045","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/sj.bjp.0704406","article-title":"Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats\u2013pharmacokinetic\/pharmacodynamic modelling","volume":"134","author":"Bouw","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejps.2015.03.020_b0055","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1016\/S0021-9258(17)30115-1","article-title":"Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity","volume":"254","author":"Chang","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2015.03.020_b0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-6576.1997.tb04625.x","article-title":"Morphine metabolites","volume":"41","author":"Christrup","year":"1997","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ejps.2015.03.020_b0065","first-page":"1","article-title":"Human UGT2B7 catalyzes morphine glucuronidation","volume":"25","author":"Coffman","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2015.03.020_b0070","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000542-200411000-00021","article-title":"Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion","volume":"101","author":"Dahan","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2165\/00003088-198207030-00006","article-title":"Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine","volume":"7","author":"Dahlstrom","year":"1982","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.03.020_b0080","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ajh.21051","article-title":"UGT2B7 promoter variant -840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease","volume":"83","author":"Darbari","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejps.2015.03.020_b0085","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/00365520310004399","article-title":"Experimental pain in gastroenterology: a reappraisal of human studies","volume":"38","author":"Drewes","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejps.2015.03.020_b0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2125.2003.02032.x","article-title":"Blood-brain barrier transport of morphine in patients with severe brain trauma","volume":"57","author":"Ederoth","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0169-2607(03)00073-7","article-title":"POPED, a software for optimal experiment design in population kinetics","volume":"74","author":"Foracchia","year":"2004","journal-title":"Comput. Meth. Progr. Biomed."},{"key":"10.1016\/j.ejps.2015.03.020_b0100","first-page":"477","article-title":"Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine","volume":"328","author":"Frances","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.ejps.2015.03.020_b0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/BIP-200040853","article-title":"Optimal population designs for PK models with serial sampling","volume":"15","author":"Gagnon","year":"2005","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.ejps.2015.03.020_b0110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/js980056f","article-title":"Morphine-3-glucuronide has a minor effect on morphine antinociception","volume":"87","author":"Gardmark","year":"1998","journal-title":"Pharmacodyn. Model. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.03.020_b0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3959(92)90065-J","article-title":"Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat","volume":"48","author":"Gong","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2015.03.020_b0120","first-page":"507","article-title":"Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3","volume":"26","author":"Green","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2015.03.020_b0125","series-title":"Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics","first-page":"547","article-title":"Opioid Analgesics","author":"Gutstein","year":"2005"},{"key":"10.1016\/j.ejps.2015.03.020_b0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejps.2015.03.020_b0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(88)91256-1","article-title":"Enterohepatic circulation of morphine","volume":"1","author":"Hanks","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2015.03.020_b0140","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000542-200504000-00018","article-title":"Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery","volume":"102","author":"Hanna","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0145","first-page":"344","article-title":"Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations","volume":"24","author":"Hasselstrom","year":"1993","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.03.020_b0150","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1093\/hmg\/9.19.2895","article-title":"Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence","volume":"9","author":"Hoehe","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejps.2015.03.020_b0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.tpj.6500139","article-title":"Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients","volume":"3","author":"Holthe","year":"2003","journal-title":"Pharmacogen. J."},{"key":"10.1016\/j.ejps.2015.03.020_b0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/bjc.1990.363","article-title":"Morphine: pharmacokinetics and clinical practice","volume":"62","author":"Hoskin","year":"1990","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejps.2015.03.020_b0170","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1476-5381.1996.tb15619.x","article-title":"Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium","volume":"118","author":"Huwyler","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0175","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1586\/14737159.8.6.689","article-title":"Are we approaching the post-blockbuster era? Pharmacodiagnostics and rational drug development","volume":"8","author":"Jorgensen","year":"2008","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.ejps.2015.03.020_b0180","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.clpt.2003.08.011","article-title":"Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine","volume":"74","author":"Kharasch","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0185","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/med.20035","article-title":"Morphine-6-glucuronide: actions and mechanisms","volume":"25","author":"Kilpatrick","year":"2005","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejps.2015.03.020_b0190","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/85115","article-title":"Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs","volume":"4","author":"King","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejps.2015.03.020_b0195","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1399-6576.2004.00517.x","article-title":"The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease","volume":"48","author":"Klepstad","year":"2004","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ejps.2015.03.020_b0200","doi-asserted-by":"crossref","first-page":"PL45-50","DOI":"10.1016\/0024-3205(94)00426-S","article-title":"The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine","volume":"56","author":"Kristensen","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2015.03.020_b0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(00)00819-0","article-title":"Opioid receptor and peptide gene polymorphisms: potential implications for addictions","volume":"410","author":"LaForge","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0215","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00007691-199310000-00014","article-title":"Determination of the serum protein binding of oxycodone and morphine using ultrafiltration","volume":"15","author":"Leow","year":"1993","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2015.03.020_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pain.2006.01.010","article-title":"Current evidence for a genetic modulation of the response to analgesics","volume":"121","author":"L\u00f6tsch","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2015.03.020_b0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-200140070-00001","article-title":"Morphine-6-glucuronide: an analgesic of the future?","volume":"40","author":"L\u00f6tsch","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.03.020_b0230","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/00000542-199712000-00014","article-title":"Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers","volume":"87","author":"L\u00f6tsch","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008571-200201000-00002","article-title":"The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine","volume":"12","author":"L\u00f6tsch","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ejps.2015.03.020_b0240","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000542-200112000-00009","article-title":"The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers","volume":"95","author":"L\u00f6tsch","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/mcp.2002.126172","article-title":"Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers","volume":"72","author":"L\u00f6tsch","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0250","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0009-9236(96)90058-2","article-title":"Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers","volume":"60","author":"L\u00f6tsch","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0255","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00000542-199904000-00016","article-title":"Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers","volume":"90","author":"L\u00f6tsch","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0260","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0009-9236(98)90086-8","article-title":"Pharmacokinetics of morphine-6-glucuronide and its formation from morphine after intravenous administration","volume":"63","author":"L\u00f6tsch","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0265","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1213\/01.ane.0000265557.73688.32","article-title":"Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites","volume":"105","author":"Mazoit","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejps.2015.03.020_b0270","first-page":"401","article-title":"Basic concepts of pharmacokinetic\/pharmacodynamic (PK\/PD) modelling","volume":"35","author":"Meibohm","year":"1997","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0275","first-page":"592","article-title":"Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine","volume":"54","author":"Meineke","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0280","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2015.03.020_b0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2125.1992.tb04107.x","article-title":"The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients","volume":"34","author":"Milne","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0290","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0090-9556(25)08214-5","article-title":"Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep","volume":"21","author":"Milne","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2015.03.020_b0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pain.2010.06.012","article-title":"Do sex differences exist in opioid analgesia? A systematic review and meta-analysis of human experimental and clinical studies","volume":"151","author":"Niesters","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2015.03.020_b0300","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1124\/pr.111.005447","article-title":"Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs","volume":"64","author":"Olesen","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2015.03.020_b0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","article-title":"Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide","volume":"47","author":"Osborne","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0310","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2125.1992.tb04121.x","article-title":"The analgesic activity of morphine-6-glucuronide","volume":"34","author":"Osborne","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0315","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/mcp.2000.111934","article-title":"Randomized placebo-controlled trial of the activity of the morphine glucuronides","volume":"68","author":"Penson","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0320","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jps.1131","article-title":"Limited phase I study of morphine-3-glucuronide","volume":"90","author":"Penson","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.03.020_b0325","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2125.2002.01554.x","article-title":"The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide","volume":"53","author":"Penson","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0330","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ejps.2015.03.020_b0335","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-3565(25)21481-1","article-title":"Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse","volume":"230","author":"Porreca","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0340","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00000542-200401000-00021","article-title":"Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences","volume":"100","author":"Romberg","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0345","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000542-200310000-00008","article-title":"Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers","volume":"99","author":"Romberg","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0350","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000542-200503000-00008","article-title":"Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response","volume":"102","author":"Romberg","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0355","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/00000542-200011000-00018","article-title":"Sex differences in morphine analgesia: an experimental study in healthy volunteers","volume":"93","author":"Sarton","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0360","first-page":"412","article-title":"The influence of active transport systems on morphine -6-glucuronide transport in MDCKII and MDCK-PGP cells","volume":"19","author":"Sattari","year":"2011","journal-title":"Daru"},{"key":"10.1016\/j.ejps.2015.03.020_b0365","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10928-007-9066-0","article-title":"Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies","volume":"34","author":"Savic","year":"2007","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2015.03.020_b0370","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A","volume":"96","author":"Schinkel","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2015.03.020_b0375","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1620\/tjem.105.45","article-title":"Analgesic effect of morphine glucuronides","volume":"105","author":"Shimomura","year":"1971","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ejps.2015.03.020_b0380","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/mcp.2003.5","article-title":"Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers","volume":"73","author":"Skarke","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0385","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(90)90619-3","article-title":"Morphine-3-glucuronide\u2013a potent antagonist of morphine analgesia","volume":"47","author":"Smith","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2015.03.020_b0390","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.clpt.6100095","article-title":"Pharmacogenetics of opioids","volume":"81","author":"Somogyi","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.03.020_b0395","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.174.4007.421","article-title":"Disposition of morphine in man","volume":"174","author":"Spector","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.ejps.2015.03.020_b0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1742-7843.2004.950301.x","article-title":"Experimental human pain models: a review of standardised methods for preclinical testing of analgesics","volume":"95","author":"Staahl","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2015.03.020_b0405","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/0091270008314465","article-title":"Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model","volume":"48","author":"Staahl","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0410","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0702873","article-title":"Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability","volume":"128","author":"Stain-Texier","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0415","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199110173251602","article-title":"Analgesic effect of intraarticular morphine after arthroscopic knee surgery","volume":"325","author":"Stein","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2015.03.020_b0420","article-title":"Modelling concentration-analgesia relationships for morphine to evaluate experimental pain models","author":"Sverrisd\u00f3ttir","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.03.020_b0425","first-page":"145","article-title":"Respiratory depression following morphine and morphine-6-glucuronide in normal subjects","volume":"40","author":"Thompson","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0430","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/00000542-200005000-00030","article-title":"Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein","volume":"92","author":"Thompson","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2015.03.020_b0435","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Phys."},{"key":"10.1016\/j.ejps.2015.03.020_b0440","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1023\/A:1023250900462","article-title":"Morphine blood-brain barrier transport is influenced by probenecid co-administration","volume":"20","author":"Tunblad","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2015.03.020_b0445","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.acpain.2006.06.002","article-title":"Population pharmacokinetic modelling of subcutaneous morphine in the elderly","volume":"8","author":"Upton","year":"2006","journal-title":"Acute Pain"},{"key":"10.1016\/j.ejps.2015.03.020_b0450","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0090-9556(25)09039-7","article-title":"Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney","volume":"19","author":"Van Crugten","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2015.03.020_b0455","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.acpain.2006.04.001","article-title":"Pharmacokinetics of M6G following intravenous and oral administration in healthy volunteers","volume":"8","author":"Villesen","year":"2006","journal-title":"Acute Pain"},{"key":"10.1016\/j.ejps.2015.03.020_b0460","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00228-007-0306-4","article-title":"Pharmacokinetics of morphine-6-glucuronide following oral administration in healthy volunteers","volume":"63","author":"Villesen","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0465","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/aps.2010.138","article-title":"The role of kappa-opioid receptor activation in mediating antinociception and addiction","volume":"31","author":"Wang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2015.03.020_b0470","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.78.10.6181","article-title":"Classification of multiple morphine and enkephalin binding sites in the central nervous system","volume":"78","author":"Wolozin","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2015.03.020_b0475","unstructured":"World Health Organization, 2004. World Health Organization supports global effort to relieve chronic pain. 2012."},{"key":"10.1016\/j.ejps.2015.03.020_b0480","first-page":"768","article-title":"Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine","volume":"25","author":"Wu","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2015.03.020_b0485","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.1840090222","article-title":"The effect of age upon liver volume and apparent liver blood flow in healthy man","volume":"9","author":"Wynne","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.ejps.2015.03.020_b0490","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0702804","article-title":"The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-\/-) and mdr1a (+\/+) mice","volume":"128","author":"Xie","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2015.03.020_b0495","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/jps.2600660921","article-title":"Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans","volume":"66","author":"Yeh","year":"1977","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.03.020_b0500","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0306-4522(97)00647-7","article-title":"Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia","volume":"85","author":"Zhang","year":"1998","journal-title":"Neuroscience"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715001207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715001207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T03:58:37Z","timestamp":1747886317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098715001207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":99,"alternative-id":["S0928098715001207"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.03.020","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of morphine and morphine-6-glucuronide\u2019s pharmacokinetic\u2013pharmacodynamic relationships in experimental and clinical pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}